COMPARISON OF THE PLASMA-LEVELS OF APOLIPOPROTEIN-B AND APOLIPOPROTEIN-A-I, AND OTHER RISK-FACTORS IN MEN AND WOMEN WITH PREMATURE CORONARY-ARTERY DISEASE

被引:166
作者
KWITEROVICH, PO
CORESH, J
SMITH, HH
BACHORIK, PS
DERBY, CA
PEARSON, TA
机构
[1] JOHNS HOPKINS MED INST, DEPT PEDIAT, LIPID RES ATHEROSCLEROSIS UNIT, 600 N WOLFE ST, CMSC 604, BALTIMORE, MD 21205 USA
[2] JOHNS HOPKINS MED INST, DEPT MED, BALTIMORE, MD 21205 USA
[3] JOHNS HOPKINS MED INST, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA
关键词
D O I
10.1016/0002-9149(92)90856-T
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The predictors of premature coronary atherosclerosis were examined in 203 patients (99 men aged less-than-or-equal-to 50 years, and 104 women aged less-than-or-equal-to 60 years) undergoing elective diagnostic coronary arteriography. Age, cigarette smoking, hypertension, obesity, diabetes, positive family history of premature coronary artery disease (CAD), and plasma levels of total cholesterol, triglyceride, lipoproteins (i.e., very low, intermediate-, low-, and high-density [HDL] lipoproteins and their subfractions [HDL2 and HDL3], and lipoprotein [a]) and apolipoproteins (apoA-1, apoA-2 and apoB, respectively) were examined using univariate analyses and multivariate logistic regression. In men, age (p < 0.05), smoking (p < 0.05), and plasma triglyceride (p < 0.02) and apoA-1 (p < 0.05) levels were independently associated with CAD. In women, smoking (p < 0.001) and plasma apoB levels (p < 0.04) were the strongest variables independently associated with CAD. It is concluded that the "nontraditional" risk factors (plasma apoA-1 and apoB levels) are better predictors of premature CAD than are plasma lipoproteins and that smoking is the strongest of the traditional nonlipid risk factors.
引用
收藏
页码:1015 / 1021
页数:7
相关论文
共 28 条
[1]  
Austen W G, 1975, Circulation, V51, P5
[2]  
Bachorik P S, 1986, Methods Enzymol, V129, P78
[3]  
BECKER DM, 1988, CARDIOVASC REV, V9, P63
[4]  
BUSH TL, 1988, CLIN CHEM, V34, pB60
[5]   DIFFERENCES IN LOW-DENSITY LIPOPROTEIN SUBFRACTIONS AND APOLIPOPROTEINS IN PREMENOPAUSAL AND POSTMENOPAUSAL WOMEN [J].
CAMPOS, H ;
MCNAMARA, JR ;
WILSON, PWF ;
ORDOVAS, JM ;
SCHAEFER, EJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (01) :30-35
[6]   ASSOCIATION OF LEVELS OF LIPOPROTEIN LP(A), PLASMA-LIPIDS, AND OTHER LIPOPROTEINS WITH CORONARY-ARTERY DISEASE DOCUMENTED BY ANGIOGRAPHY [J].
DAHLEN, GH ;
GUYTON, JR ;
ATTAR, M ;
FARMER, JA ;
KAUTZ, JA ;
GOTTO, AM .
CIRCULATION, 1986, 74 (04) :758-765
[7]   SERUM-LIPIDS, LIPOPROTEINS AND APOLIPOPROTEINS IN BLACK PATIENTS WITH ANGIOGRAPHICALLY DEFINED CORONARY-ARTERY DISEASE [J].
FORD, ES ;
COOPER, RS ;
SIMMONS, B ;
CASTANER, A .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1990, 43 (05) :425-432
[8]   PLASMA HOMOCYST(E)INE LEVELS IN MEN WITH PREMATURE CORONARY-ARTERY DISEASE [J].
GENEST, JJ ;
MCNAMARA, JR ;
SALEM, DN ;
WILSON, PWF ;
SCHAEFER, EJ ;
MALINOW, MR .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1990, 16 (05) :1114-1119
[9]   DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM [J].
HAVEL, RJ ;
EDER, HA ;
BRAGDON, JH .
JOURNAL OF CLINICAL INVESTIGATION, 1955, 34 (09) :1345-1353
[10]   PREDICTIVE VALUE OF LIPOPROTEIN (A) AND OTHER SERUM-LIPOPROTEINS IN THE ANGIOGRAPHIC DIAGNOSIS OF CORONARY-ARTERY DISEASE [J].
HEARN, JA ;
DEMAIO, SJ ;
ROUBIN, GS ;
HAMMARSTROM, M ;
SGOUTAS, D .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 66 (17) :1176-1180